1. Stocks
  2. Rocket Pharmaceuticals Inc
  3. Swot
swot-logo

Rocket Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Rocket Pharmaceuticals Inc has 13 Strengths, 15 Weaknesses, 6 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout Second Resistance ( LTP > R2)

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Rising Net Cash Flow and Cash from Operating activity

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

Positive Breakout (LTP > R2)

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Increasing profits every quarter for the past 2 quarters

Positive Breakout (LTP > R1)

Top Gainers

Stock with Low PE (PE < = 10)

Stocks with Quarter Change % less than Industry

PEG greater than Industry PEG

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Highest fall from 52 Week High

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Promoters increasing shareholding QoQ